Clinical, Serological, and Virological Analysis of 572 Chikungunya Patients From 2010 to 2013 in India
Author(s) -
Jaspreet Jain,
Kaustuv Nayak,
Neha Tanwar,
Rajni Gaind,
Bhupendra Gupta,
Jayanthi Shastri,
Raj K. Bhatnagar,
Kaja MuraliKrishna,
Anmol Chandele,
Sujatha Sunil
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix283
Subject(s) - medicine , chikungunya , serology , seroconversion , joint pain , disease , viral load , immunology , virus , antibody
Chikungunya fever (CHIK) is a major public health concern in India. Characterized by acute fever with joint pain and swelling, most patients recover from this self-limiting illness in 7-10 days, with cessation of joint pain post-acute episode. However, in some patients, joint pain persists, lasting for months or even years. The precise correlates to the chronic phase of this debilitating illness and/or this remarkable heterogeneity in disease manifestation are poorly understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom